Deep Vein Thrombosis - Impedimetric Microanalysis System (DVT-IMP)
Cenamps helped to successfully establish a European consortium who are innovating new bio-nano-micro-informatic technologies that will ultimately help clinicians rapidly diagnose patients suspected of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) at the point-of-first-contact.
To view animation of DVT leading to PE, click here.
University of Teesside are leading the consortium of ten European research and high-tech firms to develop a highly reliable, accurate, mobile and handheld medical diagnostic prototype device that can be used anytime, anywhere to rapidly diagnose patients suspected of DVT and PE. Using the latest advancements in polymer electronics, bio-molecular engineering, lab-on-a-chip, wireless ICT and nano-biotechnologies, the prototype device will detect D-dimer levels in whole blood. The results of which can be used by healthcare professionals to rule out DVT or refer the patient for further diagnosis.
As part of the project activities, the consortium will carry out a survey to identify specific requirements that need to be incorporated into the device. The project commenced on 1st September 2006 and will run for 3 years with a prototype device being developed by August 2009.
The device promises to revolutionise the speed, accuracy and reliability with which DVT and related blood clot conditions can be diagnosed at the point-of-first-contact and will enable practitioners to better perform their diagnosis and effectively reduce the number of false-positives and will be used at primary point-of-care locations including hospitals, local clinics, Accident & Emergency units, doctors’ surgery, outpatient departments and by paramedics.
The European Commission Information Society & Media Directorate General awarded €3.3M to the consortium to innovate the prototype device in addition to the consortiums own contribution of €2.2M, bringing the total R&D investment to €5.5M.
The consortium includes Cenamps, Helena Biosciences, University of Teesside, Wyeth ( Haptogen), Fraunhofer Institute, Parc Cientific de Barcelona, Claude-Bernard University-Lyon, Comenius University, Budapest University of Technology & Economics and Universite Paris-Sud.
AntiCoagulation Europe plays an important role in the project, working closely with the consortium as both advisors and observers.
DVT-IMP and Anticoagulation Europe (ACE) have launched a discussion forum that provides an online environment to discuss any aspect of anticoagulation therapy, share views and provide information.
This project is supported by funding from the European Commission Information Society & Media Directorate as part of Framework Programme 6.
To find out more about the DVT-IMP project, please visit www.diagnosingdvt.com or contact enquiries@diagnosingdvt.com
Project Website and Tools
DiagnosingDVT Online Patient Forum
Partners
Claude Bernard University Lyon 1
Budapest University of Technology and Economics